Reserve Research sells peptides and research compounds strictly for in-vitro research use only. You must be 21 years of age or older and a qualified researcher to proceed.
By entering, you confirm you are purchasing for legitimate research purposes only. These products are not intended for human or veterinary use, diagnosis, or treatment.
Research Use Only (RUO) — All products are sold exclusively for laboratory research purposes. Not for human or veterinary use.
Learn More
This vial combines two complementary growth hormone-releasing compounds: CJC-1295 No DAC and Ipamorelin, each at 5mg for a total of 10mg.
CJC-1295 No DAC is a modified form of growth hormone-releasing hormone (GHRH). It works by signaling the pituitary gland to release growth hormone (GH), and its shorter active window — compared to DAC versions — allows researchers to study more controlled, time-limited GH release patterns.
Ipamorelin is a selective growth hormone secretagogue that mimics ghrelin, a hormone produced in the stomach. Unlike some other GH-stimulating compounds, Ipamorelin triggers GH release without significantly raising cortisol or prolactin levels, making it a useful tool for studying isolated GH activity.
When used together, these two compounds produce a synergistic effect — CJC-1295 No DAC amplifies the GH pulse while Ipamorelin controls the timing and selectivity of release. This combination is commonly used in research examining the growth hormone axis, lean body mass changes, metabolic rate, bone density models, and age-related hormonal shifts.
This vial contains lyophilized CJC-1295 No DAC + Ipamorelin at ≥99% purity for each peptide, verified by independent third-party HPLC and LCMS testing.
Be the first to review “CJC-1295 No DAC + Ipamorelin” Cancel reply
Research Summary: The following information is provided for research context only.
This vial combines two complementary growth hormone-releasing compounds: CJC-1295 No DAC and Ipamorelin, each at 5mg for a total of 10mg.
CJC-1295 No DAC is a modified form of growth hormone-releasing hormone (GHRH). It works by signaling the pituitary gland to release growth hormone (GH), and its shorter active window — compared to DAC versions — allows researchers to study more controlled, time-limited GH release patterns.
Ipamorelin is a selective growth hormone secretagogue that mimics ghrelin, a hormone produced in the stomach. Unlike some other GH-stimulating compounds, Ipamorelin triggers GH release without significantly raising cortisol or prolactin levels, making it a useful tool for studying isolated GH activity.
When used together, these two compounds produce a synergistic effect — CJC-1295 No DAC amplifies the GH pulse while Ipamorelin controls the timing and selectivity of release. This combination is commonly used in research examining the growth hormone axis, lean body mass changes, metabolic rate, bone density models, and age-related hormonal shifts.
This vial contains lyophilized CJC-1295 No DAC + Ipamorelin at ≥99% purity for each peptide, verified by independent third-party HPLC and LCMS testing.
Related products
Independently tested for purity — see COA
TB-500
Research-grade TB-500 — synthetic thymosin beta-4 fragment, lyophilized, ≥99% purity. Independently third-party tested with COA included. For research…
MW1885.1 DaBatchTB5010-001
Independently tested for purity — see COA
Semaglutide
Research-grade Semaglutide — GLP-1 receptor agonist analogue, lyophilized, ≥99% purity. Independently third-party tested with COA included. For research…
MW4113.6 DaBatchSEM010-001
Independently tested for purity — see COA
Retatrutide
Retatrutide is a triple receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. It is used in research…
MW4528.2 Da
Independently tested for purity — see COA
BPC-157
BPC-157 is a synthetic peptide made up of 15 amino acids, derived from a protein naturally found in…
Reviews
There are no reviews yet.